← Leaderboards
Maddalena Adorno
Dorian Therapeutics, Inc.
$4,178,124
Attributed
$4,178,124
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$4,178,124 · 1
By mechanism
U44$4,178,124 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Collagen”
- Subba Shankar · Collamedix Inc.$4,628,486
- Ozgur Sahin · Medical University Of South Carolina$3,832,492
- Patrice Mimche · University Of Utah$3,695,376
- Ivan Pelivanov · University Of Washington$3,650,130
- David Myung · Stanford University$3,647,115
- Edgar Mauricio Espana · University Of South Florida$3,512,840
Research focus
CollagenClinical TrialsChromatinChronicAgingChromosome 21AffectAnalogAdultApoptosisBacterial Artificial ChromosomesBiochemicalBmi1 GeneChromatin Remodeling FactorAnalgesicsBurden Of IllnessCartilageCatabolismCdkn2a GeneCell AgingCell RegenerationCellsChondrocytesCongenital Disorders
Grant awards (4)
Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis$1,235,850
U44 · FY2024 · AG · contact PI
Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis$1,249,462
U44 · FY2023 · AG · contact PI
Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis$1,239,916
U44 · FY2022 · AG · contact PI
Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis$452,896
U44 · FY2021 · AG · contact PI